Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $31M | 22M | 1.41 |
| 2025-03-31 | $8.1M | 6.3M | 1.28 |
| 2024-12-31 | $5.8M | 5.4M | 1.08 |
| 2024-09-30 | $9.3M | 7.8M | 1.19 |
| 2024-06-30 | $3.8M | 3.4M | 1.11 |
| 2024-03-31 | $799k | 820k | 0.97 |
| 2023-12-31 | $1.8M | 2.0M | 0.93 |
| 2023-09-30 | $1.3M | 1.4M | 0.94 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1